A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 - Contract Pharma
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 Contract Pharma
Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate - GEN - Genetic Engineering and Biotechnology News
Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate GEN - Genetic Engineering and Biotechnology News
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure - BioProcess International
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure BioProcess International
Lonza Partners with UNH to Offer Life Sciences Scholarship and Mentorship Program | UNH Today - University of New Hampshire
Lonza Partners with UNH to Offer Life Sciences Scholarship and Mentorship Program | UNH Today University of New Hampshire
While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year - Fierce Pharma
While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year Fierce Pharma
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market - Fierce Pharma
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market Fierce Pharma
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy - Pharmaceutical Technology
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy Pharmaceutical Technology
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page